Increased warning time with darifenacin: A new concept in the management of urinary urgency

Journal of Urology

Volumn 173, Issue 4, 2005, Pages 1214-1218

  Cardozo, Linda ^a   Dixon, Andrea ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Bladder; Darifenacin; Urinary incontinence; Urination disorders

Indexed keywords

DARIFENACIN; OXYBUTYNIN; PLACEBO; PROPIVERINE; TOLTERODINE; TROSPIUM CHLORIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; HEADACHE; HUMAN; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTICENTER STUDY; OVERACTIVE BLADDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; TABLET; TIME; TREATMENT OUTCOME; URINARY URGENCY; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 15044344535     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000155798.78911.57     Document Type: Article

References (18)

1. Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U. et al: The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn, 21: 167, 2002
2. Stewart, W. F., Van Rooyen, J. B., Cundiff, G. W., Abrams, P., Herzog, A. R., Corey, R. et al: Prevalence and burden of overactive bladder in the United States. World J Urol, 20: 327, 2003
3. Nuotio, M., Jylha, M., Luukkaala, T. and Tammela, T. L.: Urgency, urge incontinence and voiding symptoms in men and women aged 70 years and over. BJU Int, 89: 350, 2002
4. Liberman, J. N., Hunt, T. L., Stewart, W. F., Wein, A., Zhou, Z., Herzog, A. R. et al: Health-related quality of life among adults with symptoms of overactive bladder: results from a U. S. community-based survey. Urology, 57: 1044, 2001
5. Diokno, A. C.: Epidemiology and psychosocial aspects of incontinence. Urol Clin North Am, 22: 481, 1995
6. van der Vaart, C. H., de Leeuw, J. R., Roovers, J. P. and Heintz, A. P.: The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int, 90: 544, 2002
7. Abrams, P., Kelleher, C. J., Kerr, L. A. and Rogers, R. G.: Overactive bladder significantly affects quality of life. Am J Manag Care, 6: S580, 2000
8. Ricci, J. A., Baggish, J. S., Hunt, T. L., Stewart, W. F., Wein, A., Herzog, A. R. et al: Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther, 23: 1245, 2001
9. Chalifoux, P.: Urinary continence/incontinence. Recognizing warning time: a critical step toward continence. Geriatr Nurs, 1: 254, 1980
10. Oliver, S., Fowler, C., Mundy, A. and Craggs, M.: Measuring the sensations of urge and bladder filling during cystometry in urge incontinence and the effects of neuromodulation. Neurourol Urodyn, 22: 7, 2003
11. Garely, A. D. and Burrows, L. J.: Current pharmacotherapeutic strategies for overactive bladder. Expert Opin Pharmacother, 3: 827, 2002
12. Andersson, K.-E., Appell, R., Awad, S., Chapple, C., Drutz, H., Finkbeiner, A. et al: Pharmacological treatment of urinary incontinence. In: Incontinence, 2nd International Consultation on Incontinence, Paris, July 1-3, 2001. Edited by P. Abrams, L. Cardozo, S. Khoury and A. J. Wein. Plymouth: Plymbridge Distributors, Ltd., chapt. 9, p. 480, 2002
13. Detrol LA Prescribing Information. LaJolla, California: Pfizer-Pharmacia, July, 2003
14. Ditropan XL Prescribing Information. Alza Corp., Mountain View, California: June, 2003
15. Andersson, K.-E.: Potential benefits of muscarinic M3 receptor selectivity. Eur Urol Suppl, 1: 23, 2002
16. Katz, I. R., Sands, L. P., Bilker, W., DiFilippo, S., Boyce, A. and D'Angelo, K.: Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc, 46: 8, 1998
17. Napier, C. and Gupta, P.: Darifenacin is selective for the human recombinant M3 receptor subtype. Presented at annual meeting of International Continence Society, Heidelberg, Germany, abstract 445, August 20-23, 2002
18. Choi, H. K., Xin, Z. C., Choi, Y. D., Lee, W. H., Mah, S. Y. and Kim, D. K.: Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomized, placebo controlled clinical study. Int J Impot Res, 11: 261, 1999